Topic: How To Invest

Power Growth Investor Hotline – Friday, July 2, 2021

Article Excerpt

BOSTON SCIENTIFIC CORP., $43.92, is a buy. The company (symbol BSX on New York) develops and markets medical devices used in minimally invasive procedures. Its products are used for angioplasty (blood vessel repair), blood clot filtration, cardiac rhythm management, catheter-aided ultrasound imaging, and many other surgical procedures. It generates 58% of its sales in the U.S. and 42% internationally. The company is now reportedly considering buying the 73% of Farapulse that it doesn’t already own. That would let Boston Scientific strengthen its global position in the area of electrophysiology. Electrophysiology assesses your heart’s electrical system, or activity, and is used to diagnose abnormal heartbeats or arrhythmia. Privately held Farapulse is developing its pulsed-field ablation system, FARAPULSE. This is a non-thermal ablation system for the treatment of atrial fibrillation and other cardiac arrhythmias. Specifically, the ablation process destroys some heart tissue to restore normal heart rhythm, particularly if the irregular rhythm has not responded to medication. Atrial fibrillation is a common heart rhythm disorder affecting…